|
|
|
| CDMO Of The Year: Cell & Gene Therapy | The CDMO Leadership Awards are based on feedback from biopharma sponsor companies and independently analyzed by Tufts Center for the Study of Drug Development. MilliporeSigma is proud to announce their distinction as 2026’s Cell & Gene Therapy CDMO of the year, and best in class distinctions for: Biologics – Technology Use and Cell & Gene Therapy - Analytical Services, Overall Staff, Project Management, Cultural Fit, Technology Use. More. |
|
|
|
|
By Tatyana Matveeva, Ph.D., Massachusetts General Hospital | Many sponsors miscast preclinical development as an unglamorous step between discovery and the clinic. Here's how the consequences may lead to irrevocable losses. | |
|
|
| Consistency Engineered For Animal‑Free Bioprocessing | Infographic | Nu-Tek Biosciences | Animal‑free soy‑based materials provide consistent molecular weight profiles, stable mineral levels, and controlled manufacturing to ensure reliable, reproducible bioprocessing performance. |
|
|
| The Cornerstones Of Cell Therapy Excellence | E-Book | Kincell Bio | Cell therapy success relies on integrated analytics, process development, quality, and manufacturing, using risk management and DoE strategies to ensure scalable, compliant, cost-effective delivery. |
|
|
| A User‑Focused Approach To Life Science Innovation | Article | Ensorcell | Explore how thoughtful engineering and user‑focused design can transform everyday lab tools into more intuitive solutions, as well as how small innovations can remove persistent workflow challenges. |
|
|
|
| Efficient Late-Stage Development Of Biologics | White Paper | ProBio | Reducing biologics manufacturing costs requires strategic late-stage process development, yield optimization, scale-up, and raw material substitution—all while maintaining product quality and regulatory compliance. |
|
|
| Put Your AAV On The Fast-Track To The Clinic | White Paper | Catalent | Review an innovative method to fast-tracking AAVs through a platform approach that easily scales as the project progresses to late-stage GMP production and to market. |
|
|
| How To Choose The Right CDMO | Article | By Amalia Soenens and Lindsey Wolf, Landmark Bio | Advanced therapy manufacturing requires deep biological expertise. Choosing a partner with translational experience and a robust CMC strategy is vital to navigating complex regulatory reviews. |
|
|
|
| Bioprocessing Summit | Elevate your expertise, embrace innovation, and connect with the global leaders transforming bioprocessing for the digital age. The Bioprocessing Summit unites a global community of scientists, engineers, and executives driving innovation and digitalization across process development, scale-up, quality, and analytics for biologics, antibodies, cell and gene, RNA, and oligonucleotide therapies. Join us August 10-13 in Boston to explore how technology, data, and AI are reshaping every stage of the bioprocessing journey. Learn more at BioprocessingSummit.com |
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
